AbbVie Strikes Again By Teeing Up $8.7bn Offer For Cerevel

 
• By Joseph Haas
  
Big deal
AbbVie will pay $8.7bn for Cerevel to boost its neurology portfolio • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business